Xenon Pharmaceuticals Inc.
Nasdaq XENE · Burnaby, British Columbia, Canada
Works in Neurology · Psychiatry
Xenon Pharmaceuticals Inc. is a clinical trial sponsor based in Burnaby, British Columbia, Canada, listed as Nasdaq XENE. It has 9 active clinical trials with 3,885 planned participants, in Neurology and Psychiatry. Since 2021 it has completed 4 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq XENE
Fundraising
Pipeline · 9 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc is lead sponsor of 9 active clinical trials on ClinicalTrials.gov, with 3,885 planned participants, in Neurology, Psychiatry. Since 2021 it has completed 4 trials and stopped 2 early.
Xenon Pharmaceuticals Inc is based in Burnaby, British Columbia, Canada and is listed as Nasdaq XENE. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Xenon Pharmaceuticals Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with Xenon Pharmaceuticals Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.